Bevacizumab-associated osteonecrosis of the jaw

Por Greuter, S., Schmid, F., Ruhstaller, T., Thuerlimann, B.
Publicado em 2008

Opto-electronic characterization of third-generation solar cells

Por Neukom, Martin, Züfle, Simon, Jenatsch, Sandra, Ruhstaller, Beat
Publicado no Sci Technol Adv Mater (2018)

Prophylactic Wound Vacuum Therapy after Cesarean Section to Prevent Wound Complications in the Obese Population: A Randomized Controlled Trial (the ProVac Study)

Por Ruhstaller, Kelly, Downes, Katheryne L., Chandrasekaran, Suchitra, Srinivas, Sindhu, Durnwald, Celeste
Publicado no Am J Perinatol (2017)

Quantitative analysis of pixel crosstalk in AMOLED displays

Por Matthias Diethelm, Lieven Penninck, Stéphane Altazin, Roman Hiestand, Christoph Kirsch, Beat Ruhstaller
Publicado em 2018-04-01

Chapter Advanced Numerical Simulation of Organic Light-emitting Devices

Por Reinke, Nils A., Müller, Felix, Rezzonico, Daniele, Ruhstaller, Beat, Perucco, Benjamin, Knapp, Evelyne
Publicado em 2011

Bevacizumab specifically decreases elevated levels of circulating KIT(+)CD11b(+) cells and IL-10 in metastatic breast cancer patients

Por Cattin, Sarah, Fellay, Benoît, Pradervand, Sylvain, Trojan, Andreas, Ruhstaller, Thomas, Rüegg, Curzio, Fürstenberger, Gregor
Publicado no Oncotarget (2016)

Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report

Por Spirig, Christian, Omlin, Aurelius, D'Addario, Giannicola, Loske, Klaus-Dieter, Esenwein, Philipp, Geismar, Jan Henning, Ruhstaller, Thomas
Publicado em 2009

Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors

Por Templeton, Arnoud J, Thürlimann, Beat, Baumann, Michael, Mark, Michael, Stoll, Sarah, Schwizer, Madeleine, Dietrich, Daniel, Ruhstaller, Thomas
Publicado em 2013

Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study

Por Varga, Zsuzsanna, Cassoly, Estelle, Li, Qiyu, Oehlschlegel, Christian, Tapia, Coya, Lehr, Hans Anton, Klingbiel, Dirk, Thürlimann, Beat, Ruhstaller, Thomas
Publicado no PLoS One (2015)

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion

Por Preusser, Matthias, De Mattos-Arruda, Leticia, Thill, Marc, Criscitiello, Carmen, Bartsch, Rupert, Ruhstaller, Thomas, de Azambuja, Evandro, Zielinski, Christoph C
Publicado no ESMO Open (2018)

Influence of chemically p-type doped active organic semiconductor on the film thickness versus performance trend in cyanine/C(60) bilayer solar cells

Por Jenatsch, Sandra, Geiger, Thomas, Heier, Jakob, Kirsch, Christoph, Nüesch, Frank, Paracchino, Adriana, Rentsch, Daniel, Ruhstaller, Beat, C Véron, Anna, Hany, Roland
Publicado no Sci Technol Adv Mater (2015)

Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness

Por Boesch, Maximilian, Onder, Lucas, Cheng, Hung-Wei, Novkovic, Mario, Mörbe, Urs, Sopper, Sieghart, Gastl, Guenther, Jochum, Wolfram, Ruhstaller, Thomas, Knauer, Michael, Ludewig, Burkhard
Publicado no Oncoimmunology (2018)

Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer

Por Koeberle, D, Burkhard, R, von Moos, R, Winterhalder, R, Hess, V, Heitzmann, F, Ruhstaller, T, Terraciano, L, Neuweiler, J, Bieri, G, Rust, C, Toepfer, M
Publicado em 2008

Oesophageal cancer: exploring controversies overview of experts’ opinions of Austria, Germany, France, Netherlands and Switzerland

Por Putora, Paul Martin, Bedenne, Laurent, Budach, Wilfried, Eisterer, Wolfgang, Van Der Gaast, Ate, Jäger, Robert, Van Lanschot, J. Jan B., Mariette, Christophe, Schnider, Annelies, Stahl, Michael, Ruhstaller, Thomas
Publicado no Radiat Oncol (2015)

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol fo...

Por Guido Henke, Michael Knauer, Karin Ribi, Stefanie Hayoz, Marie-Aline Gérard, Thomas Ruhstaller, Daniel R. Zwahlen, Simone Muenst, Markus Ackerknecht, Hanne Hawle, Florian Fitzal, Michael Gnant, Zoltan Mátrai, Bettina Ballardini, Andreas Gyr, Christian Kurzeder, Walter P. Weber
Publicado em 2018-12-01

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-0...

Por Pruneri, Giancarlo, Gray, Kathryn P., Vingiani, Andrea, Viale, Giuseppe, Curigliano, Giuseppe, Criscitiello, Carmen, Láng, István, Ruhstaller, Thomas, Gianni, Lorenzo, Goldhirsch, Aron, Kammler, Roswitha, Price, Karen N., Cancello, Giuseppe, Munzone, Elisabetta, Gelber, Richard D., Regan, Meredith M., Colleoni, Marco
Publicado no Breast Cancer Res Treat (2016)

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis...

Por Regan, M. M., Walley, B. A., Francis, P. A., Fleming, G. F., Láng, I., Gómez, H. L., Colleoni, M., Tondini, C., Pinotti, G., Salim, M., Spazzapan, S., Parmar, V., Ruhstaller, T., Abdi, E. A., Gelber, R. D., Coates, A. S., Goldhirsch, A., Pagani, O.
Publicado no Ann Oncol (2017)

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

Por Pestalozzi, Bernhard C., Tausch, Christoph, Dedes, Konstantin J., Rochlitz, Christoph, Zimmermann, Stefan, von Moos, Roger, Winterhalder, Ralph, Ruhstaller, Thomas, Mueller, Andreas, Buser, Katharina, Borner, Markus, Novak, Urban, Nussbaum, Catrina Uhlmann, Seifert, Bettina, Bigler, Martin, Bize, Vincent, Vilei, Simona Berardi, Rageth, Christoph, Aebi, Stefan
Publicado no BMC Cancer (2017)

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-neg...

Por Rochlitz, Christoph, Bigler, Martin, von Moos, Roger, Bernhard, Jürg, Matter-Walstra, Klazien, Wicki, Andreas, Zaman, Khalil, Anchisi, Sandro, Küng, Marc, Na, Kyung-Jae, Bärtschi, Daniela, Borner, Markus, Rordorf, Tamara, Rauch, Daniel, Müller, Andreas, Ruhstaller, Thomas, Vetter, Marcus, Trojan, Andreas, Hasler-Strub, Ursula, Cathomas, Richard, Winterhalder, Ralph
Publicado no BMC Cancer (2016)

Adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression: patient-reported outcomes in the TEXT and SOFT randomised trial...

Por Bernhard, Jürg, Luo, Weixiu, Ribi, Karin, Colleoni, Marco, Burstein, Harold J., Tondini, Carlo, Pinotti, Graziella, Spazzapan, Simon, Ruhstaller, Thomas, Puglisi, Fabio, Pavesi, Lorenzo, Parmar, Vani, Regan, Meredith M., Pagani, Olivia, Fleming, Gini F., Francis, Prudence A., Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Walley, Barbara A.
Publicado no Lancet Oncol (2015)